HomeCSCI • NASDAQ
add
COSCIENS Biopharma Inc
Previous close
$3.37
Day range
$3.65 - $3.74
Year range
$1.96 - $9.10
Market cap
11.85M USD
Avg Volume
3.53K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.50M | -27.08% |
Operating expense | 4.06M | 49.37% |
Net income | -3.66M | -160.89% |
Net profit margin | -243.67 | -257.76% |
Earnings per share | — | — |
EBITDA | -3.29M | -126.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.76M | -53.43% |
Total assets | 31.14M | -2.05% |
Total liabilities | 21.00M | 11.56% |
Total equity | 10.14M | — |
Shares outstanding | 3.15M | — |
Price to book | 1.05 | — |
Return on assets | -27.31% | — |
Return on capital | -64.96% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.66M | -160.89% |
Cash from operations | -1.88M | 21.01% |
Cash from investing | -615.00K | -9.04% |
Cash from financing | -200.00K | -112.77% |
Net change in cash | -2.64M | 16.93% |
Free cash flow | -1.74M | -130.76% |
About
Founded
1990
Headquarters
Website
Employees
40
